Stock listing

Lang & Schwarz:A2JAZX Cantargia AB Aktie

German listing (Lang & Schwarz) of Cantargia AB · home listing Stockholm:CANTA

Follow Cantargia AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:CANTA

1.31 SEK +0.02 (+1.2%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:CANTA

Past year -47.9% · daily closes, Oct 16, 2025 – Oct 16, 2026, adjusted for splits
Day range
1.30 – 1.32 SEKOct 16, 2026
Volume
696,745 sharesOct 16, 2026
Market value
324.7M SEKAt the close on Oct 16, 2026 · price × 248.6M shares outstanding
52-week range
1.25 – 6.59 SEKLowest and highest trades, Oct 17, 2025 – Oct 16, 2026
Cantargia AB logo
Ticker
Lang & Schwarz:A2JAZX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Calls

Replays

  • Cantargia (Stockholm:CANTA) Q2 2026 Earnings Call

    Wed, Aug 19, 2026 · 9:00 AM ET

    Watch Transcript

  • Cantargia (Stockholm:CANTA) Q1 2026 Earnings Call

    Tue, May 19, 2026 · 9:00 AM ET

    Watch Transcript

  • Cantargia (Stockholm:CANTA) Q4 2025 Earnings Call

    Fri, Feb 20, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

Cantargia to Host Q2 2026 Interim Results Conference Call

Aug 4, 2026

Cantargia: Cantargia Announces Changes in Number of Shares and Votes

Jul 31, 2026

Cantargia Announces Changes in Number of Shares and Votes

Jul 31, 2026

Cantargia Announces Publication of Data Supporting IL1RAP as a Therapeutic Target and Predictive Biomarker in PDAC

Jun 26, 2026

Cantargia announces outcome in rights issue and resolves on a directed issue of warrants to Fenja Capital

Jun 23, 2026

Cantargia publishes Information Document regarding Rights Issue of Shares

Jun 5, 2026

Cantargia AB to Host Webcast Covering Rights Issue, Loan Agreement, and Strategic Priorities

May 28, 2026

Bulletin from the Annual General Meeting in Cantargia AB (publ)

May 21, 2026

Cantargia Publishes Interim Report for The First Quarter of 2026

May 19, 2026

Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML

Apr 27, 2026

All Cantargia AB news

Decks

Cantargia AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
23 in the last 12 months · 45 in all · newest Aug 4, 2026 · oldest 2025
Calls
10 calls with a replay · 10 with a transcript · latest Aug 19, 2026
Decks
72 decks · latest Sep 14, 2026

Where Cantargia AB is listed

ListingExchangeCountryCurrency
Stockholm:CANTA · Home listingStockholmSwedenSEK
gettex:7V3gettexGermanyEUR
LS Exchange:A2JAZXLS ExchangeGermanyEUR
Aquis:CANTASAquisUnited KingdomSEK
Aquis:CANTASAquisUnited KingdomSEK
Dusseldorf:7V3DusseldorfGermanyEUR
Frankfurt:7V3FrankfurtGermanyEUR
Lang & Schwarz:A2JAZX · This pageLang & SchwarzGermanyEUR
Munich:7V3MunichGermanyEUR
Stuttgart:7V3StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Cantargia AB.